PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
As the global economy mends, the 2021 growth of Short Bowel Syndrome will have significant change from previous year. According to our (LP Information) latest study, the global Short Bowel Syndrome market size is USD million in 2022 from USD 434.5 million in 2021, with a change of % between 2021 and 2022. The global Short Bowel Syndrome market size will reach USD 1374.5 million in 2028, growing at a CAGR of 17.9% over the analysis period. The United States Short Bowel Syndrome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Short Bowel Syndrome market, reaching US$ million by the year 2028. As for the Europe Short Bowel Syndrome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period. Global main Short Bowel Syndrome players cover Takeda, Merck, Emmaus Life Sciences, and Nutrinia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of Short Bowel Syndrome market by product type, application, key players and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7. GLP-2 Growth Hormone Glutamine Others Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8. Hospitals Clinics This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3. Takeda Merck Emmaus Life Sciences Nutrinia GlyPharma Therapeutics OxThera Ardelyx Sancilio & Company Naia Pharmaceuticals Zealand Pharma
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Short Bowel Syndrome Market Size 2017-2028
2.1.2 Short Bowel Syndrome Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Short Bowel Syndrome Segment by Type
2.2.1 GLP-2
2.2.2 Growth Hormone
2.2.3 Glutamine
2.2.4 Others
2.3 Short Bowel Syndrome Market Size by Type
2.3.1 Short Bowel Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Short Bowel Syndrome Market Size Market Share by Type (2017-2022)
2.4 Short Bowel Syndrome Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Short Bowel Syndrome Market Size by Application
2.5.1 Short Bowel Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Short Bowel Syndrome Market Size Market Share by Application (2017-2022)
3 Short Bowel Syndrome Market Size by Player
3.1 Short Bowel Syndrome Market Size Market Share by Players
3.1.1 Global Short Bowel Syndrome Revenue by Players (2020-2022)
3.1.2 Global Short Bowel Syndrome Revenue Market Share by Players (2020-2022)
3.2 Global Short Bowel Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Short Bowel Syndrome by Regions
4.1 Short Bowel Syndrome Market Size by Regions (2017-2022)
4.2 Americas Short Bowel Syndrome Market Size Growth (2017-2022)
4.3 APAC Short Bowel Syndrome Market Size Growth (2017-2022)
4.4 Europe Short Bowel Syndrome Market Size Growth (2017-2022)
4.5 Middle East & Africa Short Bowel Syndrome Market Size Growth (2017-2022)
5 Americas
5.1 Americas Short Bowel Syndrome Market Size by Country (2017-2022)
5.2 Americas Short Bowel Syndrome Market Size by Type (2017-2022)
5.3 Americas Short Bowel Syndrome Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short Bowel Syndrome Market Size by Region (2017-2022)
6.2 APAC Short Bowel Syndrome Market Size by Type (2017-2022)
6.3 APAC Short Bowel Syndrome Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Short Bowel Syndrome by Country (2017-2022)
7.2 Europe Short Bowel Syndrome Market Size by Type (2017-2022)
7.3 Europe Short Bowel Syndrome Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Short Bowel Syndrome by Region (2017-2022)
8.2 Middle East & Africa Short Bowel Syndrome Market Size by Type (2017-2022)
8.3 Middle East & Africa Short Bowel Syndrome Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Short Bowel Syndrome Market Forecast
10.1 Global Short Bowel Syndrome Forecast by Regions (2023-2028)
10.1.1 Global Short Bowel Syndrome Forecast by Regions (2023-2028)
10.1.2 Americas Short Bowel Syndrome Forecast
10.1.3 APAC Short Bowel Syndrome Forecast
10.1.4 Europe Short Bowel Syndrome Forecast
10.1.5 Middle East & Africa Short Bowel Syndrome Forecast
10.2 Americas Short Bowel Syndrome Forecast by Country (2023-2028)
10.2.1 United States Short Bowel Syndrome Market Forecast
10.2.2 Canada Short Bowel Syndrome Market Forecast
10.2.3 Mexico Short Bowel Syndrome Market Forecast
10.2.4 Brazil Short Bowel Syndrome Market Forecast
10.3 APAC Short Bowel Syndrome Forecast by Region (2023-2028)
10.3.1 China Short Bowel Syndrome Market Forecast
10.3.2 Japan Short Bowel Syndrome Market Forecast
10.3.3 Korea Short Bowel Syndrome Market Forecast
10.3.4 Southeast Asia Short Bowel Syndrome Market Forecast
10.3.5 India Short Bowel Syndrome Market Forecast
10.3.6 Australia Short Bowel Syndrome Market Forecast
10.4 Europe Short Bowel Syndrome Forecast by Country (2023-2028)
10.4.1 Germany Short Bowel Syndrome Market Forecast
10.4.2 France Short Bowel Syndrome Market Forecast
10.4.3 UK Short Bowel Syndrome Market Forecast
10.4.4 Italy Short Bowel Syndrome Market Forecast
10.4.5 Russia Short Bowel Syndrome Market Forecast
10.5 Middle East & Africa Short Bowel Syndrome Forecast by Region (2023-2028)
10.5.1 Egypt Short Bowel Syndrome Market Forecast
10.5.2 South Africa Short Bowel Syndrome Market Forecast
10.5.3 Israel Short Bowel Syndrome Market Forecast
10.5.4 Turkey Short Bowel Syndrome Market Forecast
10.5.5 GCC Countries Short Bowel Syndrome Market Forecast
10.6 Global Short Bowel Syndrome Forecast by Type (2023-2028)
10.7 Global Short Bowel Syndrome Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Short Bowel Syndrome Product Offered
11.1.3 Takeda Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Short Bowel Syndrome Product Offered
11.2.3 Merck Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Emmaus Life Sciences
11.3.1 Emmaus Life Sciences Company Information
11.3.2 Emmaus Life Sciences Short Bowel Syndrome Product Offered
11.3.3 Emmaus Life Sciences Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Emmaus Life Sciences Main Business Overview
11.3.5 Emmaus Life Sciences Latest Developments
11.4 Nutrinia
11.4.1 Nutrinia Company Information
11.4.2 Nutrinia Short Bowel Syndrome Product Offered
11.4.3 Nutrinia Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Nutrinia Main Business Overview
11.4.5 Nutrinia Latest Developments
11.5 GlyPharma Therapeutics
11.5.1 GlyPharma Therapeutics Company Information
11.5.2 GlyPharma Therapeutics Short Bowel Syndrome Product Offered
11.5.3 GlyPharma Therapeutics Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GlyPharma Therapeutics Main Business Overview
11.5.5 GlyPharma Therapeutics Latest Developments
11.6 OxThera
11.6.1 OxThera Company Information
11.6.2 OxThera Short Bowel Syndrome Product Offered
11.6.3 OxThera Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 OxThera Main Business Overview
11.6.5 OxThera Latest Developments
11.7 Ardelyx
11.7.1 Ardelyx Company Information
11.7.2 Ardelyx Short Bowel Syndrome Product Offered
11.7.3 Ardelyx Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Ardelyx Main Business Overview
11.7.5 Ardelyx Latest Developments
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Information
11.8.2 Sancilio & Company Short Bowel Syndrome Product Offered
11.8.3 Sancilio & Company Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sancilio & Company Main Business Overview
11.8.5 Sancilio & Company Latest Developments
11.9 Naia Pharmaceuticals
11.9.1 Naia Pharmaceuticals Company Information
11.9.2 Naia Pharmaceuticals Short Bowel Syndrome Product Offered
11.9.3 Naia Pharmaceuticals Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Naia Pharmaceuticals Main Business Overview
11.9.5 Naia Pharmaceuticals Latest Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Information
11.10.2 Zealand Pharma Short Bowel Syndrome Product Offered
11.10.3 Zealand Pharma Short Bowel Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Zealand Pharma Main Business Overview
11.10.5 Zealand Pharma Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Short Bowel Syndrome Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions) Table 2. Major Players of GLP-2 Table 3. Major Players of Growth Hormone Table 4. Major Players of Glutamine Table 5. Major Players of Others Table 6. Short Bowel Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions) Table 7. Global Short Bowel Syndrome Market Size by Type (2017-2022) & ($ Millions) Table 8. Global Short Bowel Syndrome Market Size Market Share by Type (2017-2022) Table 9. Short Bowel Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions) Table 10. Global Short Bowel Syndrome Market Size by Application (2017-2022) & ($ Millions) Table 11. Global Short Bowel Syndrome Market Size Market Share by Application (2017-2022) Table 12. Global Short Bowel Syndrome Revenue by Players (2020-2022) & ($ Millions) Table 13. Global Short Bowel Syndrome Revenue Market Share by Player (2020-2022) Table 14. Short Bowel Syndrome Key Players Head office and Products Offered Table 15. Short Bowel Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Short Bowel Syndrome Market Size by Regions 2017-2022 & ($ Millions) Table 19. Global Short Bowel Syndrome Market Size Market Share by Regions (2017-2022) Table 20. Americas Short Bowel Syndrome Market Size by Country (2017-2022) & ($ Millions) Table 21. Americas Short Bowel Syndrome Market Size Market Share by Country (2017-2022) Table 22. Americas Short Bowel Syndrome Market Size by Type (2017-2022) & ($ Millions) Table 23. Americas Short Bowel Syndrome Market Size Market Share by Type (2017-2022) Table 24. Americas Short Bowel Syndrome Market Size by Application (2017-2022) & ($ Millions) Table 25. Americas Short Bowel Syndrome Market Size Market Share by Application (2017-2022) Table 26. APAC Short Bowel Syndrome Market Size by Region (2017-2022) & ($ Millions) Table 27. APAC Short Bowel Syndrome Market Size Market Share by Region (2017-2022) Table 28. APAC Short Bowel Syndrome Market Size by Type (2017-2022) & ($ Millions) Table 29. APAC Short Bowel Syndrome Market Size Market Share by Type (2017-2022) Table 30. APAC Short Bowel Syndrome Market Size by Application (2017-2022) & ($ Millions) Table 31. APAC Short Bowel Syndrome Market Size Market Share by Application (2017-2022) Table 32. Europe Short Bowel Syndrome Market Size by Country (2017-2022) & ($ Millions) Table 33. Europe Short Bowel Syndrome Market Size Market Share by Country (2017-2022) Table 34. Europe Short Bowel Syndrome Market Size by Type (2017-2022) & ($ Millions) Table 35. Europe Short Bowel Syndrome Market Size Market Share by Type (2017-2022) Table 36. Europe Short Bowel Syndrome Market Size by Application (2017-2022) & ($ Millions) Table 37. Europe Short Bowel Syndrome Market Size Market Share by Application (2017-2022) Table 38. Middle East & Africa Short Bowel Syndrome Market Size by Region (2017-2022) & ($ Millions) Table 39. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Region (2017-2022) Table 40. Middle East & Africa Short Bowel Syndrome Market Size by Type (2017-2022) & ($ Millions) Table 41. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Type (2017-2022) Table 42. Middle East & Africa Short Bowel Syndrome Market Size by Application (2017-2022) & ($ Millions) Table 43. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Application (2017-2022) Table 44. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome Table 45. Key Market Challenges & Risks of Short Bowel Syndrome Table 46. Key Industry Trends of Short Bowel Syndrome Table 47. Global Short Bowel Syndrome Market Size Forecast by Regions (2023-2028) & ($ Millions) Table 48. Global Short Bowel Syndrome Market Size Market Share Forecast by Regions (2023-2028) Table 49. Global Short Bowel Syndrome Market Size Forecast by Type (2023-2028) & ($ Millions) Table 50. Global Short Bowel Syndrome Market Size Market Share Forecast by Type (2023-2028) Table 51. Global Short Bowel Syndrome Market Size Forecast by Application (2023-2028) & ($ Millions) Table 52. Global Short Bowel Syndrome Market Size Market Share Forecast by Application (2023-2028) Table 53. Takeda Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 54. Takeda Short Bowel Syndrome Product Offered Table 55. Takeda Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 56. Takeda Main Business Table 57. Takeda Latest Developments Table 58. Merck Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 59. Merck Short Bowel Syndrome Product Offered Table 60. Merck Main Business Table 61. Merck Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 62. Merck Latest Developments Table 63. Emmaus Life Sciences Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 64. Emmaus Life Sciences Short Bowel Syndrome Product Offered Table 65. Emmaus Life Sciences Main Business Table 66. Emmaus Life Sciences Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 67. Emmaus Life Sciences Latest Developments Table 68. Nutrinia Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 69. Nutrinia Short Bowel Syndrome Product Offered Table 70. Nutrinia Main Business Table 71. Nutrinia Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 72. Nutrinia Latest Developments Table 73. GlyPharma Therapeutics Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 74. GlyPharma Therapeutics Short Bowel Syndrome Product Offered Table 75. GlyPharma Therapeutics Main Business Table 76. GlyPharma Therapeutics Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 77. GlyPharma Therapeutics Latest Developments Table 78. OxThera Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 79. OxThera Short Bowel Syndrome Product Offered Table 80. OxThera Main Business Table 81. OxThera Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 82. OxThera Latest Developments Table 83. Ardelyx Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 84. Ardelyx Short Bowel Syndrome Product Offered Table 85. Ardelyx Main Business Table 86. Ardelyx Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 87. Ardelyx Latest Developments Table 88. Sancilio & Company Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 89. Sancilio & Company Short Bowel Syndrome Product Offered Table 90. Sancilio & Company Main Business Table 91. Sancilio & Company Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 92. Sancilio & Company Latest Developments Table 93. Naia Pharmaceuticals Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 94. Naia Pharmaceuticals Short Bowel Syndrome Product Offered Table 95. Naia Pharmaceuticals Main Business Table 96. Naia Pharmaceuticals Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 97. Naia Pharmaceuticals Latest Developments Table 98. Zealand Pharma Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors Table 99. Zealand Pharma Short Bowel Syndrome Product Offered Table 100. Zealand Pharma Main Business Table 101. Zealand Pharma Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 102. Zealand Pharma Latest Developments List of Figures Figure 1. Short Bowel Syndrome Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Short Bowel Syndrome Market Size Growth Rate 2017-2028 ($ Millions) Figure 6. Global Short Bowel Syndrome Market Size Market Share by Type in 2021 Figure 7. Short Bowel Syndrome in Hospitals Figure 8. Global Short Bowel Syndrome Market: Hospitals (2017-2022) & ($ Millions) Figure 9. Short Bowel Syndrome in Clinics Figure 10. Global Short Bowel Syndrome Market: Clinics (2017-2022) & ($ Millions) Figure 11. Global Short Bowel Syndrome Market Size Market Share by Application in 2021 Figure 12. Global Short Bowel Syndrome Revenue Market Share by Player in 2021 Figure 13. Global Short Bowel Syndrome Market Size Market Share by Regions (2017-2022) Figure 14. Americas Short Bowel Syndrome Market Size 2017-2022 ($ Millions) Figure 15. APAC Short Bowel Syndrome Market Size 2017-2022 ($ Millions) Figure 16. Europe Short Bowel Syndrome Market Size 2017-2022 ($ Millions) Figure 17. Middle East & Africa Short Bowel Syndrome Market Size 2017-2022 ($ Millions) Figure 18. Americas Short Bowel Syndrome Value Market Share by Country in 2021 Figure 19. Americas Short Bowel Syndrome Consumption Market Share by Type in 2021 Figure 20. Americas Short Bowel Syndrome Market Size Market Share by Application in 2021 Figure 21. United States Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 22. Canada Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 23. Mexico Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 24. Brazil Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 25. APAC Short Bowel Syndrome Market Size Market Share by Region in 2021 Figure 26. APAC Short Bowel Syndrome Market Size Market Share by Application in 2021 Figure 27. China Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 28. Japan Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 29. Korea Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 30. Southeast Asia Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 31. India Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 32. Australia Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 33. Europe Short Bowel Syndrome Market Size Market Share by Country in 2021 Figure 34. Europe Short Bowel Syndrome Market Size Market Share by Type in 2021 Figure 35. Europe Short Bowel Syndrome Market Size Market Share by Application in 2021 Figure 36. Germany Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 37. France Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 38. UK Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 39. Italy Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 40. Russia Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 41. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Region in 2021 Figure 42. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Type in 2021 Figure 43. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Application in 2021 Figure 44. Egypt Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 45. South Africa Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 46. Israel Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 47. Turkey Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 48. GCC Country Short Bowel Syndrome Market Size Growth 2017-2022 ($ Millions) Figure 49. Americas Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 50. APAC Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 51. Europe Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 52. Middle East & Africa Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 53. United States Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 54. Canada Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 55. Mexico Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 56. Brazil Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 57. China Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 58. Japan Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 59. Korea Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 60. Southeast Asia Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 61. India Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 62. Australia Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 63. Germany Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 64. France Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 65. UK Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 66. Italy Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 67. Russia Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 68. Spain Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 69. Egypt Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 70. South Africa Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 71. Israel Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 72. Turkey Short Bowel Syndrome Market Size 2023-2028 ($ Millions) Figure 73. GCC Countries Short Bowel Syndrome Market Size 2023-2028 ($ Millions)
Takeda Merck Emmaus Life Sciences Nutrinia GlyPharma Therapeutics OxThera Ardelyx Sancilio & Company Naia Pharmaceuticals Zealand Pharma
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape